NCT07594548 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT07594548
Title	Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Recruitment	Not yet recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Northwestern University
Indications	gastric adenocarcinoma gastroesophageal junction adenocarcinoma esophagus adenocarcinoma
Therapies	Futibatinib + Paclitaxel + Ramucirumab
Age Groups:	adult \| senior
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Northwestern University		Chicago	Illinois	60611	United States	Details
Ohio State University		Columbus	Ohio	43210	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT07594548Clinical Trial Detail